Morgan Sanford | Director of Investor Relations |
Ludwig Hantson | Chief Executive Officer |
Aradhana Sarin | Chief Financial Officer |
John Orloff | Global Head of R&D |
Brian Goff | Chief Commercial and Global Operations Officer |
Cory Kasimov | JP Morgan |
Geoff Meacham | Bank of America |
Geoffrey Porges | SVB Leerink |
Chris Raymond | Piper Sandler |
Josh Schimmer | Evercore |
Kostas Biliouris | Morgan Stanley |
Robyn Karnauskas | SunTrust Robinson |
Mohit Bansal | Citigroup |
Kennen MacKay | RBC Capital Markets |
Ladies and gentlemen, thank you for standing by and welcome to the Alexion Pharmaceuticals Fourth Quarter and Full Year 2019 Results Conference Call. At this time, all participant lines are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. Please be advised, that today's conference may be recorded.
I would now like to hand the conference over to Morgan Sanford, Director, Investor Relations.